| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/19/2011 | US7981382 Device for collecting, testing and storing fluids |
| 07/19/2011 | US7981364 Gas detection method and system |
| 07/19/2011 | US7981363 System and method for analyte measurement |
| 07/19/2011 | US7981362 Modular assay plates, reader systems and methods for test measurements |
| 07/19/2011 | US7981352 Method and apparatus for quality surveillance during the manufacture of tablets |
| 07/19/2011 | US7981237 Micro- or nano-fluidic chip fabricated with Norland Optical Adhesive and bioanalysis platform produced by using the same |
| 07/19/2011 | US7981055 Tissue penetration device |
| 07/19/2011 | CA2727501A1 Electrode layout for blood test sensor strip |
| 07/19/2011 | CA2727500A1 Sensor strip positioning mechanism |
| 07/19/2011 | CA2589707C Test element comprising nanofibers |
| 07/19/2011 | CA2566859C Modulation of wrn-mediated telomere-initiated cell signaling |
| 07/19/2011 | CA2525978C Process for increasing ionic charge in mass spectrometry |
| 07/19/2011 | CA2518667C Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
| 07/19/2011 | CA2514741C Strokes shift emission spectroscopy for detection of disease and physiological state of specimen |
| 07/19/2011 | CA2473218C Disease susceptibility gene for rheumatoid arthritis, protein thereof, evaluation method and evaluation kit for evaluating onset possibility of rheumatoid arthritis by using those, and remedy and curing medicine for rheumatoid arthritis |
| 07/19/2011 | CA2467046C Process for the manufacture of human mononuclear phagocytic leukocytes |
| 07/19/2011 | CA2456115C Potentiometric probe compounds |
| 07/19/2011 | CA2451347C Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
| 07/19/2011 | CA2437681C Diagnostic kit with a memory storing test strip calibration codes and related methods |
| 07/19/2011 | CA2433501C Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/19/2011 | CA2420279C Selective androgen receptor modulators and methods of use thereof |
| 07/19/2011 | CA2419254C Compositions and methods for detecting target microorganisms in a sample |
| 07/19/2011 | CA2407296C An imaging fluorometer for time resolved fluorescence |
| 07/19/2011 | CA2401906C Kcnb: a novel potassium channel protein |
| 07/19/2011 | CA2397354C O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/19/2011 | CA2373119C Polysaccharide structure and sequence determination |
| 07/19/2011 | CA2355352C Detecting nucleic acids using exciplex formation |
| 07/19/2011 | CA2290018C Magnetically assisted binding assays utilizing a magnetically responsive reagent |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/18/2011 | CA2785774A1 Tumor tissue based biomarkers for bevacizumab combination therapies |
| 07/14/2011 | WO2011085258A2 Fluidics interface system |
| 07/14/2011 | WO2011085219A2 Method and apparatus for forming of an automated sampling device for the detection of salmonella enterica utilizing an electrochemical aptamer biosensor |
| 07/14/2011 | WO2011085213A2 Pathologically-activated therapeutics |
| 07/14/2011 | WO2011085176A2 Fret-based method for the determination of protein phosphatase and kinase activity |
| 07/14/2011 | WO2011085165A2 Ca-125 immune complexes as biomarkers of ovarian cancer |
| 07/14/2011 | WO2011085163A2 Protein markers for lung cancer detection and methods of using thereof |
| 07/14/2011 | WO2011085057A2 Methods for detecting insulin autoantibody |
| 07/14/2011 | WO2011085002A1 Serum spla2-iia as diagnosis marker for prostate and lung cancer |
| 07/14/2011 | WO2011084791A2 Early marker of proteinuria in patients treated with an anti-vegf treatment |
| 07/14/2011 | WO2011084772A2 Allelic disorders caused by mutations in trpv4 |
| 07/14/2011 | WO2011084763A1 Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion |
| 07/14/2011 | WO2011084703A2 Enzyme assays on a droplet actuator |
| 07/14/2011 | WO2011084697A2 Novel assays for detecting analytes in samples and kits and compositions related thereto |
| 07/14/2011 | WO2011084659A1 Transgenic non-human animal and uses thereof |
| 07/14/2011 | WO2011084656A1 Estimation of reservoir permeability |
| 07/14/2011 | WO2011084649A2 High energy density redox flow device |
| 07/14/2011 | WO2011084641A2 Gold coating of rare earth nano-phosphors and uses thereof |
| 07/14/2011 | WO2011084605A1 Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same |
| 07/14/2011 | WO2011084604A2 Flavivirus species-specific peptide tags for vaccine and diagnostic use |
| 07/14/2011 | WO2011084598A1 High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers |
| 07/14/2011 | WO2011084548A2 Methods and compositions for detecting recesssive familial fsgs and uses thereof |
| 07/14/2011 | WO2011084523A2 Ulk1 compositions, inhibitors, screening and methods of use |
| 07/14/2011 | WO2011084158A1 Reflection densitometer |
| 07/14/2011 | WO2011084108A1 Methods and compositions for treating cancer |
| 07/14/2011 | WO2011084101A1 Aseptic connection of separation or reaction systems |
| 07/14/2011 | WO2011084047A2 Identification of molecular markers associated with fatty acid composition in plants |
| 07/14/2011 | WO2011084044A1 Serum infection markers for diagnosis of toxoplasmosis |
| 07/14/2011 | WO2011083830A1 Novel anticancer agent and method for screening same |
| 07/14/2011 | WO2011083754A1 Fluorescence detection apparatus, fluorescence detection method, and method for processing fluorescence signal |
| 07/14/2011 | WO2011083637A1 Therapeutic agent for hepatic disorder |
| 07/14/2011 | WO2011083604A1 Reagent composition for immunochromatography |
| 07/14/2011 | WO2011083461A2 Method for diagnosing and monitoring schizophrenia and tauopathies |
| 07/14/2011 | WO2011083391A2 Biomarkers for anti-igf-ir cancer therapy |
| 07/14/2011 | WO2011083319A1 Apparatus and method for characterising sag in fluids |
| 07/14/2011 | WO2011083296A1 T cell clonotypes |
| 07/14/2011 | WO2011083285A1 Organ-specific feline endothelial cells and uses thereof |
| 07/14/2011 | WO2011083145A1 Determination of exosomel biomarkers for predicting cardiovascular events |
| 07/14/2011 | WO2011083099A1 Crystals of mutant bace - 1 |
| 07/14/2011 | WO2011083089A1 Progastrin and liver pathologies |
| 07/14/2011 | WO2011082884A1 Device for measuring a composition of a fuel mixture |
| 07/14/2011 | WO2011082820A1 Sample characterization based on ac measurement methods |
| 07/14/2011 | WO2011061376A3 Use of cd98 as endometrial receptivity marker |
| 07/14/2011 | WO2011061373A3 Quantification of bovine polyomavirus (bpyv) for tracing bovine contamination in the environment |
| 07/14/2011 | WO2011050384A3 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
| 07/14/2011 | WO2011040613A8 Therapeutic agent for tumor |
| 07/14/2011 | WO2011037348A3 Microorganism analyzer, and analysis method using same |
| 07/14/2011 | WO2011035067A3 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development |
| 07/14/2011 | WO2011032123A3 Method for determining asphaltene stability of a hydrocarbon-containing material |
| 07/14/2011 | WO2011031497A3 Quantitative fluorescent protein standards |
| 07/14/2011 | WO2011031493A3 Galectin-3 and cardiac resynchronization therapy |
| 07/14/2011 | WO2011028912A3 A biomarker for neurodegeneration in neurological disease |
| 07/14/2011 | WO2011028818A3 High throughput multichannel reader and uses thereof |
| 07/14/2011 | WO2011028697A3 Uses of cd 116 expression level |
| 07/14/2011 | WO2011028507A3 Compositions, methods, and kits for determining an alkyl transferase |
| 07/14/2011 | WO2011026613A3 Method and arrangement for recording and evaluating metabolic processes |
| 07/14/2011 | WO2011025976A3 Methods of detaching and collecting cells |
| 07/14/2011 | WO2011017605A3 Device and methods for the immunological identification of cerebrospinal fluid |
| 07/14/2011 | WO2011012764A3 Method for identifying senescent mesenchymal stem cells |
| 07/14/2011 | WO2011009981A3 Method for preparing thin films for chemical optical sensors |
| 07/14/2011 | WO2011009976A3 Method for detecting and identifying species of the family sparidae |
| 07/14/2011 | WO2011006145A3 Compositions and methods for mammalian genetics and uses thereof |
| 07/14/2011 | WO2010144150A3 Real-time analytical methods and systems |
| 07/14/2011 | WO2009149359A8 Survival predictor for diffuse large b cell lymphoma |
| 07/14/2011 | US20110173727 Endophyte Enhanced Seedlings with Increased Pest Tolerance |
| 07/14/2011 | US20110173711 eNos Mutations Useful for Gene Therapy and Therapeutic Screening |
| 07/14/2011 | US20110173708 Novel gene disruptions, compositions and methods relating thereto |
| 07/14/2011 | US20110173706 Novel gpr101 transgenic mice and methods of use thereof |
| 07/14/2011 | US20110172926 Generating, viewing, interpreting, and utilizing a quantitive database of metabolites |
| 07/14/2011 | US20110172925 Secondary Structure Defining Database And Methods For Determining Identity And Geographic Origin Of An Unknown Bioagent Thereby |
| 07/14/2011 | US20110172406 Molecular structure of rhd negative |